O2Micro (OIIM) warns it expects Q4 revenue of $16M-$17M, below prior guidance of $17M-$20M and a consensus of $18.6M. The company, no stranger to warnings, blames "broad-based weakness in demand in our end markets, coupled with lower than normal inventories being held in the supply chain." At least a few other chipmakers have similar problems. Shares are likely to fall after rising 8% in regular trading. (PR)
Analog/security chipmaker O2Micro (OIIM) warns it expects Q3 revenue of $22M-$23.1M, below prior guidance of $24.1M-$26M and a consensus of $24.8M. The company blames "broad-based weakness in demand in the company's end markets," and claims customers are working through excess inventory. Chalk this up as another negative datapoint for the chip industry. (SIA data) (FBR)
Analog and security chipmaker O2Micro (OIIM) falls 11.6% AH after warning it expects Q2 revenue of $27.9M-$28.5M, below a prior guidance range of $30.3M-$31.8M and a consensus of $31M. In a troubling sign for the chip industry, which has seen evidence of a stalled recovery mount, O2Micro attributes the warning to "broad-based weakness in demand."
O2Micro (OIIM) is awarded 13 patents for its Battery Cell Monitor and Balance IC. The patent is a continuation of an existing one - issued to the company in April, 2010 - that monitors cells and balances voltage levels of cells in battery packs for notebook computers, cell phones, PDAs, and other devices with multi-cell rechargeable batteries. Despite the award, shares are trading -4.9% AH.
O2Micro International, Ltd., designs, develops and markets integrated circuits and solutions for manufacturers of products in the consumer electronics, computer, industrial, communications, and automotive markets.